INS and Alzheimer disease: Interestingly, the pathways related to AD, such as glutamatergic synapse, GABAergic synapse, peroxisome proliferator-activated receptor (PPAR-γ), and insulin signaling pathways, were reduced in the MD and positive groups, compared to the normal group.